RESTON, Virginia, July 9 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:

* * *

FDA Grants Supplemental Indication Approvals to Three Amyloid PET Imaging Agents, Expanding the Role of Nuclear Medicine in Neurology

*

SNMMI commends the U.S. Food and Drug Administration (FDA) for recognizing the critical role of nuclear medicine in Alzheimer's and dementia imaging and therapy.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products